Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Triple O Medical Services | Researchclopedia

Back to institutions

Triple O Medical Services

West Palm Beach, Floridahealthcare

56

Works

2,760

Citations

20

h-index

Top Research Topics

HIV/AIDS drug development and treatment HIV Research and Treatment HIV/AIDS Research and Interventions

Top Researchers

Olayemi Osiyemi Triple O Medical Services

73 works3,873 citationsh-index: 26

Recent Research

Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trial

Amy E. Colson,Anthony Mills,et al.

20264 citations

HIV-related health complications and treatments

Pharmacological Effects and Toxicity Studies

Pregnancy and Medication Impact

Hepatitis C virus research

Chronic Lymphocytic Leukemia Research

Long-Term Effects of COVID-19

Immunodeficiency and Autoimmune Disorders

Pneumocystis jirovecii pneumonia detection and treatment

COVID-19 Clinical Research Studies

Lawrence A. Trissel

192 works2,790 citationsh-index: 24

Jason Ohayon Hamilton Health Sciences

45 works243 citationsh-index: 5

Myriam Izquierdo Triple O Medical Services

5 works77 citationsh-index: 3

Jakub Michańków

17 works54 citationsh-index: 2

OO Osiyemi Triple O Medical Services

1 works50 citationsh-index: 1

P-365. Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment

Kimberly Workowski,Peter Ruane,et al.

20260 citations

P-377. Efficacy and Safety by Age After Switch to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily: Week 48 Results from Two Phase 3 Randomized, Active-Controlled Studies in Adults Living with HIV-1

Pablo Tebas,Frank A Post,et al.

20260 citations

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study

Onyema Ogbuagu,Andrew Wiznia,et al.

20250 citations

The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV

Yanan Zheng,Mary Beth Wire,et al.

20250 citations

Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab

Joseph J. Eron,Paul Cook,et al.

20255 citations